# Subclinical Atherosclerosis in Patients With Familial Hypercholesterolemia Treated With Evolocumab®

> **NCT04313270** · — · UNKNOWN · sponsor: **Federico II University** · enrollment: 25 (estimated)

## Conditions studied

- Hypercholesterolemia, Familial

## Interventions

- **DRUG:** Evolocumab

## Key facts

- **NCT ID:** NCT04313270
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04313270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04313270, "Subclinical Atherosclerosis in Patients With Familial Hypercholesterolemia Treated With Evolocumab®". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04313270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*